Skip to main content


Polymyalgia rheumatica

20-11-2018 | Polymyalgia rheumatica | Article

Comorbidities in polymyalgia rheumatica: A systematic review

Partington R et al. Arthritis Res Ther 2018; 20: 258. doi: 10.1186/s13075-018-1757-y

29-08-2018 | Giant cell arteritis | Article

Additional costs of polymyalgia rheumatica with giant‐cell arteritis

Mounié M et al. Arthritis Care Res 2018. doi: 10.1002/acr.23736

12-04-2018 | Osteoporosis | Article | News

Trial results back denosumab as a treatment option for glucocorticoid-induced osteoporosis

Patients with glucocorticoid-induced osteoporosis who are treated with denosumab have greater improvements in bone mineral density than those treated with risedronate, phase III trial results suggest.

02-03-2018 | Tocilizumab | Review | Article

A review of recent advances using tocilizumab in the treatment of rheumatic diseases

Rubbert-Roth A et al. Rheumatol Ther 2018; Advance online publication. doi: 10.1007/s40744-018-0102-x

22-01-2018 | Polymyalgia rheumatica | News

Polymyalgia rheumatica, giant cell arteritis associated with increased fracture risk

Patients with polymyalgia rheumatica or giant cell arteritis have an elevated risk for fracture compared with the general population, results of a UK database study suggest.

15-07-2016 | Giant cell arteritis | Article

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population

UK clinical data were obtained and prevalence of giant cell arteritis and polymyalgia rheumatic were found to be higher in women than in men and in older age groups.

Yates M et al. BMC Musculoskelet Disord 2016;17:285. doi:10.1186/s12891-016-1127-3

08-05-2016 | Polymyalgia rheumatica | Case report | Article

Glucocorticoid-resistant polymyalgia rheumatica: Pretreatment characteristics and tocilizumab therapy

This case-based review reports on characteristics and outcomes of glucocorticoid-resistant polymyalgia rheumatica, and the addition of tocilizumab with or without methotrexate. 

Mori S, Koga Y. Clin Rheumatol 2016; 35: 1367–1375. doi:10.1007/s10067-014-2650-y

11-04-2016 | Vasculitis | Review | Article

Use of FDG-PET Scan for the assessment of large vessel vasculitis

The authors of this research propose that the diagnostic performance of EULAR/PRINTO/PRES classification criteria had higher sensitivity and specificity than the ACR criteria in adult IgA vasculitis. 

Blockmans D. Curr Treat Options in Rheum 2016;2:153–160. doi:10.1007/s40674-016-0044-9

14-01-2016 | Quality of life | Review | Article

Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review

The authors determined that although several patient-reported outcomes have been identified additional work is needed to obtain a better insight into the required outcomes that incorporate the patient’s perspective.

Rheumatol Int 2016;36:897. doi:10.1007/s00296-015-3416-9

Image Credits